Dysfunctional uterine bleeding other diagnostic studies

Dysfunctional uterine bleeding Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dysfunctional uterine bleeding from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dysfunctional uterine bleeding other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dysfunctional uterine bleeding other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dysfunctional uterine bleeding other diagnostic studies
CDC on Dysfunctional uterine bleeding other diagnostic studies
Dysfunctional uterine bleeding other diagnostic studies in the news
Blogs on Dysfunctional uterine bleeding other diagnostic studies
Directions to Hospitals Treating Dysfunctional uterine bleeding
Risk calculators and risk factors for Dysfunctional uterine bleeding other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]

Other Diagnostic Studies

• Diagnostic dilatation and curettage provides more information than biopsy, but is more invasive
• Prothrombin time / partial thromboplastin time (PT/PTT)
• Biopsy of endometrial and progesterone challenge test reveal estrogen excess
• The uterine cavirty and endometrium may be evaluated by hysteroscopy.